Alprazolam is classed as a high-potency benzodiazepine and is a triazolobenzodiazepine,[REF][REF] namely a benzodiazepine with a triazole ring attached to its structure.
Administration of alprazolam, as compared to lorazepam, has been demonstrated to elicit a statistically significant increase in extracellular dopamine D1 and D2 concentrations in the striatum [REF].